The study and treatment of peripheral neuropathies and neuralgia has become an important field of research. The pain associated with these pathological conditions has not yet been fully understood and still have not received the due interest in the common neurological tests. The pain caused by peripheral neuropathy or neuralgia, sometimes sporadic or chronic, may be resistant to treatment. However, a treatment regimen well-adjusted and applied to a unit of pain therapy, offers the best guarantees of a successful outcome, compared to other specialized approaches.Have been proposed different terms to define this type of pain linked to changes in the neurological functions, but what is now the preferred term, precisely, of neuropathic pain which only indicates its origin from functional abnormality of the nervous system.
[...] Effective therapy in the treatment of atypical facial neuralgia, and in some pain from neuropathy of the face was found to block the ganglion sfenopalatino. The block can be performed twice a week and does not need special equipment and brilliance of the amplifier. You run through Transnasal and in outpatient settings as low-toxic and not an invasive technique. The classic technique provides the direct application of lidocaine or drip directly targeted at the end of the middle turbinate and the upper near the foramen sfenopalatino with the patient supine, the neck slightly hyperesthesia. [...]
[...] The tocainide, other oral antiarrhythmic, appears to be useful in the treatment of certain neuralgias (400 mg orally three times a day) and mexiletine has proved effective in cases of neuropathy secondary to diabetes mellitus (200 mg orally three times daily The introduction in the treatment of neuropathic pain of gabapentin to medprotina, vigabatrin and lamotrigine is opening new therapeutic opportunities, especially as regards their association with pure analgesics. Between these and in this specific area, is producing a good effect on the tramadol. [...]
[...] This opioid narcotic less and probably not able to do well for its multiple function. Indeed, acting at receptor level m of morphine inhibits the reuptake of norepinephrine and serotonin (main neutrasmettitori tract of descending modulation of pain) and blocks break through the pain, typical of the phases of exacerbation. The recommended dosage is 200/250 mg / day orally, in drops or in slow-release form, is associated with antidepressants that the antiepileptic. Stimulation of Afferent Fibers Neuralgia in the use of TENS can achieve positive rates. [...]
[...] Indeed, the early block of conduction through local anesthetic long as ropivacina and bupivacaina, preverrebbe pain with a mechanism such as "preemptive." The surgery on the peripheral nervous system often cause the appearance of neuroma, neuralgia and pain from deafferentazione. So certain is the careful selection of patients and to make a traditional therapy before surgical treatment of neuropathic pain. Another objective of the therapy of neuralgia include peripheral mobilization struck to avoid a deterioration resulting from the state of non-use of art, with a consequent reduction in central nervous stimuli from immobilization. [...]
[...] Features The pain is perceived in the absence of a tissue injury or permanent and identifiable; There are unpleasant sensations, abnormal or unusual (dysesthesia), frequently referred to as burning or electric shock; There are brief episodes of paroxysmal pain of a piercing or pierced; The pain is behind the trigger lesion; The pain is perceived in a region of sensory deficit; Even lighter are painful stimuli (allodynia); There is a marked summation and persistent activity after application of repeated stimuli. [...]
using our reader.